ArticleToxicological sciences : an official journal of the Society of Toxicology2022

Gut-Selective Design of Orally Administered Izencitinib (TD-1473) Limits Systemic Exposure and Effects of Janus Kinase Inhibition in Nonclinical Species.

Rhiannon N Hardwick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.